EMTRICITABINE-TENOFOVIR DISOP (emtricitabine/tenofovir disoproxil fumarate)
TENOFOVIR · HIV INFECTION ·+1
TEVA USA
Drug class
Antiviral-HIV PrEP Therapies
While "Antiviral-HIV PrEP Therapies" is an administrative or formulary grouping rather than a distinct pharmacological class, it describes antiretroviral medications utilized for human immunodeficiency virus type 1 (HIV-1) pre-exposure prophylaxis. Read more about Antiviral-HIV PrEP Therapies
20 drugs in this class 17 manufacturers
Drugs in Antiviral-HIV PrEP Therapies
EMTRICITABINE-TENOFOVIR DISOP (emtricitabine/tenofovir disoproxil fumarate)
TENOFOVIR · HIV INFECTION ·+1
Amneal Pharmaceuticals
Filter & compare in the drug finder →
Opens the drug finder with Antiviral-HIV PrEP Therapies preselected. Add indication or manufacturer filters there.
While "Antiviral-HIV PrEP Therapies" is an administrative or formulary grouping rather than a distinct pharmacological class, it describes antiretroviral medications utilized for human immunodeficiency virus type 1 (HIV-1) pre-exposure prophylaxis.
These regimens encompass multiple mechanistic classes—most commonly nucleoside/nucleotide reverse transcriptase inhibitors, integrase strand transfer inhibitors, and capsid inhibitors—that interfere with essential viral replication cycles following potential exposure.
They are specifically indicated for HIV-negative adults and adolescents at substantial risk of acquiring HIV-1 infection through sexual contact or injection drug use.
-
fda.gov
While "Antiviral-HIV PrEP Therapies" is an administrative or formulary grouping rather than a distinct pharmacological class, it describes antiretroviral medications utilized for human immunodeficiency virus type 1 (HIV-1) pre-exposure prophylaxis
-
nih.gov
While "Antiviral-HIV PrEP Therapies" is an administrative or formulary grouping rather than a distinct pharmacological class, it describes antiretroviral medications utilized for human immunodeficiency virus type 1 (HIV-1) pre-exposure prophylaxis These regimens encompass multiple mechanistic classes—most commonly nucleoside/nucleotide reverse transcriptase inhibitors, integrase strand transfer inhibitors, and capsid inhibitors—that interfere with essential viral replication cycles following pot...
-
nih.gov
These regimens encompass multiple mechanistic classes—most commonly nucleoside/nucleotide reverse transcriptase inhibitors, integrase strand transfer inhibitors, and capsid inhibitors—that interfere with essential viral replication cycles following potential exposure
-
gilead.com
These regimens encompass multiple mechanistic classes—most commonly nucleoside/nucleotide reverse transcriptase inhibitors, integrase strand transfer inhibitors, and capsid inhibitors—that interfere with essential viral replication cycles following potential exposure
-
fda.gov
They are specifically indicated for HIV-negative adults and adolescents at substantial risk of acquiring HIV-1 infection through sexual contact or injection drug use
-
cdc.gov
They are specifically indicated for HIV-negative adults and adolescents at substantial risk of acquiring HIV-1 infection through sexual contact or injection drug use
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.